Speaker(s): 

Evangelo (Angelo) Victoros, GMC Pharmacy Intern - has nothing to disclose 

Tyler Jeffrey, GMC Pharmacy Intern - has nothing to disclose 

Lorrin Surmick, GMC Pharmacy Intern - has nothing to disclose

Moderator(s): 

Sarah Hale, Pharm.D., BCPPS. Director of Pharmacy, Geisinger-has nothing to disclose 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Identify the outcomes of pain relief between intravenous ketamine vs nebulized ketamine for the use of acute pain relief in the emergency department. 

• Evaluate the clinical advantages and disadvantages of nebulized ketamine vs intravenous ketamine for the use of acute pain in the emergency department.

• Discuss deprescribing practices of CNS-active medications in geriatric patients as an alternative method for preventing falls and injuries.

• Apply the data and bottom-line recommendation to clinical practice in the hospital setting.

• Describe the use of biologics during pregnancy in patients with their respective autoimmune conditions.

• Understand the benefits and drawbacks associated with biologics during pregnancy. 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Brain Simpkins, PharmD, Jessica Milheim, CPhT, and Tiffany Tang, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None